化学试剂 | 北京灵宝科技委托生产,技术转让,CDMO,OEM,ODM,CRO,CMO,菌珠构建,化药合成工艺转让;基因编辑;新药证书转让;临床批件转让;项目融资;CRA;CRC

产品中心

产品编号	产品名称	CAS NO.
Delf-16430	人Burkitt's淋巴瘤细胞daudi+cas9
Delf-16428	人胃癌细胞SNU-16+cas9
Delf-16431	人早幼粒白血病细胞HL-60+cas9
Delf-16432	人急性淋巴母细胞性白血病细胞MOLT-4+cas9
Delf-16433	人乳腺上皮细胞MCF-10A+cas9
Delf-16435	人前列腺癌细胞DU145+cas9
Delf-16434	人乳腺导管癌细胞T47D+cas9
Delf-16436	人前列腺癌LNCaP clone FGC+cas9
Delf-16437	人皮肤成纤维细胞hs865.sk+cas9
Delf-16438	人卵巢癌细胞SK-OV-3+cas9
Delf-16440	人套细胞淋巴瘤细胞JeKo-1+cas9
Delf-16439	人胶质母细胞瘤T98G+cas9
Delf-16441	人套细胞淋巴瘤细胞REC-1+cas9
Delf-16442	人B淋巴瘤细胞SU-DHL-4+cas9
Delf-16443	人组织细胞淋巴瘤细胞U-937+cas9
Delf-16445	人淋巴细胞瘤细胞系mino+cas9
Delf-16444	人B淋巴细胞瘤细胞RAMOS+cas9
Delf-16446	人结直肠腺癌细胞LS174T+cas9
Delf-16447	人纤维肉瘤细胞HT-1080+cas9
Delf-16449	人结直肠腺癌上皮细胞DLD-1+cas9
Delf-16448	人结肠癌细胞COLO205+cas9
Delf-16451	人结肠腺癌细胞T84+cas9
Delf-16450	人横纹肌肉瘤细胞RD+cas9
Delf-16453	人骨肉瘤细胞MG-63+cas9
Delf-16454	人骨肉瘤细胞U2OS+cas9
Delf-16452	人子宫颈鳞癌细胞SiHa+cas9
Delf-16456	人肺癌细胞A427+cas9
Delf-16455	人大细胞肺癌细胞NCI-H661+cas9
Delf-16457	人肝癌细胞hep3b2.1-7+cas9
Delf-16459	MKN-45/Oxaliplatin(人胃癌奥沙利铂耐药株
Delf-16458	人大细胞肺癌细胞NCI-H460+cas9
Delf-16460	U-251MG/Temozolomide(人神经胶质细胞瘤细胞替莫唑胺耐药株)
Delf-16461	FaDu/DDP(人咽鳞癌顺铂耐药株)
Delf-16463	MCF7/DDP(人乳腺癌顺铂耐药性细胞)
Delf-16465	Hela/DDP(人宫颈癌顺铂耐药株)
Delf-16466	OVCAR- 3/DDP(人卵巢腺癌顺铂耐药株)
Delf-16462	PC-9GR 人肺癌细胞（PC-9吉非替尼耐药株）
Delf-16468	KYSE150/DDP(人食管鳞癌顺铂耐药株)
Delf-16467	Eca109/DDP(人食管癌顺铂耐药株)
Delf-16470	CCRF-CEM/Taxol(人急性淋巴细胞白血病紫杉醇耐药株)
Delf-16471	SK-OV-3/Taxol(人卵巢腺癌紫杉醇耐药株)
Delf-16469	CAL-27/DDP(人舌磷癌细胞顺铂耐药株)
Delf-16472	Hela/Taxol(人宫颈癌细胞紫杉醇耐药株)
Delf-16473	MDA-MB-231/Taxol(人乳腺癌紫杉醇耐药株)
Delf-16474	PLC-PRF-5-sorafenib(人肝癌亚历山大索拉非尼耐药株)
Delf-16476	786-0-sorafenib(人肾透明细胞腺癌索拉非尼耐药株)
Delf-16475	HCCL M3-sorafenib(人高转移肝癌索拉非尼耐药株)
Delf-16478	RBE/5-FU(人胆管癌氟尿嘧啶耐药株)
Delf-16477	ACHN-sorafenib(人肾细胞腺癌索拉非尼耐药株)
Delf-16479	K562/ADR(人白血病阿霉素耐药株)
Delf-16481	HCC827/GR(人肺腺癌吉非替尼耐药株)
Delf-16480	K562/matinib(人慢性髓系白血病伊马替尼耐药株)
Delf-16482	HepG2/ADR(人肝癌阿霉素耐药株)
Delf-16483	LOVO-L(人结肠癌奥沙利铂耐药株)

第 1106 页 / 共 1157 页第一页上一页下一页最末页转到